Luc R.C.W. van Lonkhuijzen
Papers
1
Total Citations
22
H-Index
1
About
Dr. Luc R.C.W. van Lonkhuijzen is a leading gynecologic oncologist whose research focuses on advancing surgical treatments for ovarian cancer, particularly through minimally invasive approaches. His major contributions center on evaluating the feasibility and safety of laparoscopic cytoreduction following neoadjuvant chemotherapy in high-grade epithelial ovarian cancer—a field where high-quality evidence remains scarce despite growing clinical adoption. His landmark 2024 study, which has already garnered 22 citations, critically assessed the potential for a full-scale randomized clinical trial to address this evidence gap, highlighting both the promise and the risks of expanding minimally invasive surgery in advanced disease. Beyond this, Dr. van Lonkhuijzen has shaped international guidelines on ovarian cancer management and is recognized for bridging the divide between surgical innovation and rigorous clinical validation. His work underscores a commitment to evidence-based practice in a rapidly evolving field, making him a key voice in the ongoing debate over the role of laparoscopy in cytoreductive surgery. For students and researchers, his career exemplifies the vital interplay between technical progress and methodological caution in oncology.
Research Focus
Key Achievements
Top Papers
- 1